CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,216 enrolled
Drug / intervention
pharmacy-based PrEP deliveryother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04558554
NCT04558554N/ACompleted
CompareCT.gov

Pharmacy Delivery to Expand the Reach of PrEP in Kenya: Pilot Study

University of Washington·interventional·Posted Sep 22, 2020·Updated Mar 15, 2024

In Brief

A clinical study evaluating pharmacy-based PrEP delivery for HIV Prevention. Completed, enrolled 1,216 participants across 2 sites.

Detailed Summary

3 consecutive studies to test a novel model for PrEP initiation and refills in Kenya: pharmacy-based PrEP delivery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Prevention
CountriesKenya
CollaboratorsNational Institute of Mental Health (NIMH), National Institute of Allergy and Infectious Diseases (NIAID), Bill and Melinda Gates Foundation

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 22, 2020
Enrollment StartNov 26, 2020
Primary CompletionJul 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.8 years ago

Interventions

pharmacy-based PrEP deliveryother

The intervention is a new model of PrEP delivery that has never been tried before in an African setting: pharmacy-based PrEP delivery.